Drug intelligence / Profile preview

dendrobine

Development stage
Preclinical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Not Established In Humans (experimental; Routes In Animal Studies: Oral, Intragastric, In Vitro)
01

Overview

**Dendrobine** is a naturally occurring tetracyclic sesquiterpene alkaloid chiefly isolated from the medicinal orchid Dendrobium nobile Lindl. It displays a range of pharmacological activities including neuroprotective, antiviral (notably anti-influenza activity), anticancer (notably pro-apoptotic effects in cancer cell lines), anxiolytic, and anti-inflammatory effects. Mechanistically, dendrobine antagonizes β-alanine and taurine in the central nervous system and modulates presynaptic inhibition. It inhibits influenza A viral replication via binding the viral nucleoprotein (NP), restraining NP nuclear export, and impeding NP oligomerization. In oncology models, dendrobine promotes mitochondrial-dependent apoptosis through upregulating pro-apoptotic Bax and downregulating anti-apoptotic Bcl-2. Neuropharmacological studies indicate enhancement of neurotransmission, synaptic function, and serotonin levels, suggesting potential roles in neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, and in mood regulation[1][2][4][6][7][13][15].

Other names
(-)-Dendrobine(1S,4S,7S,8S,11S,12R,13S)-2,12-Dimethyl-13-propan-2-yl-10-oxa-2-azatetracyclo[5.4.1.1^8,11^.0^4,12^]tridecan-9-one
02

Targets

Glycine receptor

Beyond the preview

Go deeper on dendrobine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dendrobine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call